Home » Topics » Drugs » Immuno-oncology

Immuno-oncology
RSS

Japan approves Perjeta for HER2-positive inoperable or recurrent breast cancer

June 28, 2013

EMD Serono creates immune-oncology research and early development platform

June 28, 2013

Phase I study of MORAb-066 commences

June 27, 2013

Preliminary results from phase II trial of DN24-02 in urothelial cancer

June 27, 2013

Prima BioMed to begin three phase II trials of CVac

June 27, 2013

Combinatorial strategies to enhance antitumor efficacy of monoclonal antibodies

June 27, 2013

PsiOxus Therapeutics begins second study of ColoAd1 vaccine

June 21, 2013

Updated phase I/II results for daratumumab in advanced MM

June 20, 2013

Roche presents final stage 1 results from obinutuzumab study

June 18, 2013

Phase I/II clinical studies of ublituximab presented at the EHA conference

June 17, 2013

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
mRNA flu vaccine can activate broad germinal center response
BioWorld
On the eve of the June 17 Vaccines and Related Biological Products Advisory Committee (VRBPAC) meeting, which will discuss Moderna Inc.’s mRNA-1010, researchers...
GLP-1s need technologies for long-term use
BioWorld
For the long-term impact of GLP-1 therapies in obesity to be realized, they must be paired with data and digital tools. While the drugs are effective, challenges...
UTRN gene involved in arthrogryposis, study finds
BioWorld Science
Arthrogryposis multiplex congenita (AMC) is a group of disorders defined by two or more contractures in different body areas; while genes encoding sarcomeric...